Last deal

$10.03M
Local Amount - SEK 105.32M

Amount

Post-IPO Equity

Stage

09.08.2024

Date

2

all rounds

$33.7M

Total amount

date founded

Financing round

General

About Company
Ascelia develops drug candidates for diseases with unmet clinical needs.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1999

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Ascelia Pharma AB is an oncology-focused drug development company based in Malmo, Sweden. They are currently working on two clinical-stage drug candidates: Mangoral, a liver imaging drug agent for detecting liver metastases using MRI, and Oncoral, a chemotherapeutic agent for the treatment of advanced gastric cancer. Their goal is to improve the life expectancy and quality of life for cancer patients.
Contacts
Similar Companies
999
Pulmagen Therapeutics

Pulmagen Therapeutics

Pulmagen is a drug development company that focuses on creating innovative drugs for chronic respiratory diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Slough, UK

total rounds

1
7TM Pharma

7TM Pharma

7TM Pharma is a biotech company focused on discovering and developing drugs for various diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

2800 Lyngby, Denmark

total rounds

6

total raised

$82.67M
Redx Pharma

Redx Pharma

Redx Pharma is a UK-based biotechnology company focused on developing precision medicines for oncology and fibrotic diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

Macclesfield, UK

total rounds

8

total raised

$103.11M
MEI Pharma

MEI Pharma

MEI Pharma is a San Diego-based pharmaceutical company developing and commercializing novel cancer therapies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

San Diego, CA, USA

total rounds

5

total raised

$160.36M

Financials

Funding Rounds
2
2

Number of Funding Rounds

$33.7M

Money Raised

Their latest funding was raised on 09.08.2024. Their latest round Post-IPO Equity

Date 
Funding Round 
Investors 
Money Raised 
Lead 
09.08.2024
$10.03M
Local Amount - SEK 105.32M
17.03.2021
5
$23.68M
Local Amount - SEK 200M
Co-Investors
Investors
5
0

Number of lead investors

5

Number of investors

Investor 
Lead 
Round 
Partners 
No
Post-IPO Equity
No
Post-IPO Equity
No
Post-IPO Equity
Handelsbanken

Handelsbanken

Svenska Handelsbanken AB is a Swedish bank that offers corporate transactions and investment banking.

Sector

Banks

Subsector

Banks

Location

Stockholm, Sweden

total rounds

1

total raised

$1B

count Of Investments

14
Sunstone Life Science Ventures

Sunstone Life Science Ventures

Sunstone Life Science Ventures is a European venture capital firm based in Copenhagen that invests in early-stage life science companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Copenhagen, Denmark

count Of Investments

43

count Of Exists

6
Oresund Healthcare Management

Oresund Healthcare Management

Øresund-Healthcare Capital is a venture capital firm that invests in healthcare companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Health Care, Financial Services, Venture Capital

Location

2800 Lyngby, Denmark

count Of Investments

1

People

Employee Profiles
3
Carl Bjartmar

Carl Bjartmar

Chief Medical Officer

Kristian Borbos

Kristian Borbos

CFO

Magnus Corfitzen

Magnus Corfitzen

CEO

Activity

Recent News
0